Genetic testing all women for breast cancer might not be worth the cost

Women who are carriers of mutated BRCA genes are known to have a significantly higher risk for developing breast and ovarian cancers than those who don’t have the mutations. But a new study questions the value of screening for the genetic mutations in the general population—including those who do not have cancer or have no family history of the disease— because of the high cost. —> Read More